Evidence map›Paper›PMID 33925506›Full record

ArticleInternational journal of environmental research and public health2021

Follow-Up Survey of the Impact of COVID-19 on People Living with HIV during the Second Semester of the Pandemic.

Joseph Nelson Siewe Fodjo, Edlaine Faria de Moura Villela, Stijn Van Hees, Pieter Vanholder, Patrick Reyntiens, Robert Colebunders

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Childhood trauma, substance use and depressive symptoms in people with HIV during COVID-19.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. HIV and COVID-19: review of clinical course and outcomes.HIV research & clinical practice · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joseph Nelson Siewe FodjoGlobal Health Institute, University of Antwerp, 2610 Wilrijk, Belgium.ORCID 0000-0003-3544-1239
Edlaine Faria de Moura VillelaDisease Control Coordination, State Health Department, São Paulo 01246000, Brazil.ORCID 0000-0002-7043-2007
Stijn Van HeesGlobal Health Institute, University of Antwerp, 2610 Wilrijk, Belgium.ORCID 0000-0003-4296-8493
Pieter VanholderEuropean AIDS Treatment Group, 1000 Brussels, Belgium.
Patrick ReyntiensSensoa, Flemish Expertise Centre for Sexual Health, 2060 Antwerp, Belgium.
Robert ColebundersGlobal Health Institute, University of Antwerp, 2610 Wilrijk, Belgium.ORCID 0000-0002-1919-1340

Funding

H2020 European Research Council 671055Vlaamse Interuniversitaire Raad NA
6 · The paper itself

Abstract

COVID-19 affects persons living with HIV (PLWH) both directly (via morbidity/mortality) and indirectly (via disruption of HIV care). From July-November 2020, an online survey was conducted to investigate the psychosocial well-being of PLWH and changes in HIV care during the second semester of the COVID-19 outbreak. Data were collected on the socio-demographic characteristics of PLWH, their psychosocial well-being, impact of COVID-19 preventive measures on their daily routines and HIV follow-up. Of the 247 responses analyzed (mean age: 44.5 ± 13.2 years; 73.7% male), 67 (27.1%) and 69 (27.9%) respondents screened positive for anxiety (GAD-2 score ≥ 3) and depression (PHQ-2 score ≥ 3), respectively. HIV care had returned to pre-COVID-19 state for 48.6% PLWH, and 108 (43.7%) had no HIV follow-up during the past month. Over three quarters (76.1%) of respondents expressed willingness to receive the COVID-19 vaccine. Compared to previous findings in April 2020, substance use increased from 58.6% to 67.2% (

Indexed as

COVID-19HIV InfectionsAdultCOVID-19 VaccinesFemaleFollow-Up StudiesHumansMaleMiddle AgedPandemicsSARS-CoV-2Surveys and QuestionnairesCOVID-19 VaccinesCOVID-19GAD-2HIV carepersons living with HIVPHQ-2vaccination

Identifiers

PMID33925506
PMCPMC8123847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.